Aspergillus fumigatus-induced IL-22 is not restricted to a specific Th cell subset and is dependent on complement receptor 3

Journal of Immunology

Volumn 190, Issue 11, 2013, Pages 5629-5639

  Gresnigt, Mark S ^a   Becker, Katharina L ^a   Smeekens, Sanne P ^a   Jacobs, Cor W M ^a   Joosten, Leo A B ^a   Van Der Meer, Jos W M ^a   Netea, Mihai G ^a   Van De Veerdonk, Frank L ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 1,3 GLUCAN; BETA GLUCAN; COMPLEMENT RECEPTOR; COMPLEMENT RECEPTOR 3; DECTIN 1; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 22; INTERLEUKIN 23; PATTERN RECOGNITION RECEPTOR; PROTEIN KINASE SYK; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; ASPERGILLUS FUMIGATUS; CD4+ T LYMPHOCYTE; CELL POPULATION; COMPLEMENT ACTIVATION; CONIDIUM; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; FUNGUS HYPHAE; HUMAN; HUMAN CELL; LYMPHOCYTE SUBPOPULATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR BLOCKING; TH1 CELL; TH17 CELL;

ASPERGILLUS FUMIGATUS; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKINS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LECTINS, C-TYPE; PROTEIN-TYROSINE KINASES; RECEPTORS, COMPLEMENT; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, HELPER-INDUCER; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 84878077706     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1202601     Document Type: Article

References (65)

1. McCormick, A., L. Heesemann, J. Wagener, V. Marcos, D. Hartl, J. Loeffler, J. Heesemann, and F. Ebel. 2010. NETs formed by human neutrophils inhibit growth of the pathogenic mold Aspergillus fumigatus. Microbes Infect. 12: 928-936.
2. Romani, L. 2011. Immunity to fungal infections. Nat. Rev. Immunol. 11: 275-288.
3. Werner, J. L., A. E. Metz, D. Horn, T. R. Schoeb, M. M. Hewitt, L. M. Schwiebert, I. Faro-Trindade, G. D. Brown, and C. Steele. 2009. Requisite role for the dectin-1 β-glucan receptor in pulmonary defense against Aspergillus fumigatus. J. Immunol. 182: 4938-4946.
4. Werner, J. L., M. A. Gessner, L. M. Lilly, M. P. Nelson, A. E. Metz, D. Horn, C. W. Dunaway, J. Deshane, D. D. Chaplin, C. T. Weaver, et al. 2011. Neutrophils produce interleukin 17A (IL-17A) in a dectin-1- and IL-23-dependent manner during invasive fungal infection. Infect. Immun. 79: 3966-3977.
5. Zelante, T., A. De Luca, P. Bonifazi, C. Montagnoli, S. Bozza, S. Moretti, M. L. Belladonna, C. Vacca, C. Conte, P. Mosci, et al. 2007. IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur. J. Immunol. 37: 2695-2706. (Pubitemid 47578289)
6. Zelante, T., S. Bozza, A. De Luca, C. D'Angelo, P. Bonifazi, S. Moretti, G. Giovannini, F. Bistoni, and L. Romani. 2009. Th17 cells in the setting of Aspergillus infection and pathology. Med. Mycol. 47(Suppl. 1): S162-S169.
7. Chai, L. Y., F. van de Veerdonk, R. J. Marijnissen, S. C. Cheng, A. L. Khoo, M. Hectors, K. Lagrou, A. G. Vonk, J. Maertens, L. A. Joosten, et al. 2010. Anti-Aspergillus human host defence relies on type 1 T helper (Th1), rather than type 17 T helper (Th17), cellular immunity. Immunology 130: 46-54.
8. Grazziutti, M. L., J. H. Rex, R. E. Cowart, E. J. Anaissie, A. Ford, and C. A. Savary. 1997. Aspergillus fumigatus conidia induce a Th1-type cytokine response. J. Infect. Dis. 176: 1579-1583. (Pubitemid 27518159)
9. Cenci, E., A. Mencacci, G. Del Sero, A. Bacci, C. Montagnoli, C. F. d'Ostiani, P. Mosci, M. Bachmann, F. Bistoni, M. Kopf, and L. Romani. 1999. Interleukin-4 causes susceptibility to invasive pulmonary aspergillosis through suppression of protective type I responses. J. Infect. Dis. 180: 1957-1968.
10. Centeno-Lima, S., H. Silveira, C. Casimiro, P. Aguiar, and V. E. do Rosário. 2002. Kinetics of cytokine expression in mice with invasive aspergillosis: lethal infection and protection. FEMS Immunol. Med. Microbiol. 32: 167-173. (Pubitemid 34124116)
11. Gessner, M. A., J. L. Werner, L. M. Lilly, M. P. Nelson, A. E. Metz, C. W. Dunaway, Y. R. Chan, W. Ouyang, G. D. Brown, C. T. Weaver, and C. Steele. 2012. Dectin-1 dependent IL-22 contributes to early innate lung defense against Aspergillus fumigatus. Infect. Immun. 80: 410-417.
12. Lilly, L. M., M. A. Gessner, C. W. Dunaway, A. E. Metz, L. Schwiebert, C. T. Weaver, G. D. Brown, and C. Steele. 2012. The β-glucan receptor dectin-1 promotes lung immunopathology during fungal allergy via IL-22. J. Immunol. 189: 3653-3660.
13. Liang, S. C., X. Y. Tan, D. P. Luxenberg, R. Karim, K. Dunussi-Joannopoulos, M. Collins, and L. A. Fouser. 2006. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J. Exp. Med. 203: 2271-2279. (Pubitemid 44498362)
14. Dhiman, R., M. Indramohan, P. F. Barnes, R. C. Nayak, P. Paidipally, L. V. Rao, and R. Vankayalapati. 2009. IL-22 produced by human NK cells inhibits growth of Mycobacterium tuberculosis by enhancing phagolysosomal fusion. J. Immunol. 183: 6639-6645.
15. Eyerich, S., K. Eyerich, D. Pennino, T. Carbone, F. Nasorri, S. Pallotta, F. Cianfarani, T. Odorisio, C. Traidl-Hoffmann, H. Behrendt, et al. 2009. Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J. Clin. Invest. 119: 3573-3585.
16. Paget, C., S. Ivanov, J. Fontaine, J. Renneson, F. Blanc, M. Pichavant, L. Dumoutier, B. Ryffel, J. C. Renauld, P. Gosset, et al. 2012. Interleukin-22 is produced by invariant natural killer T lymphocytes during influenza A virus infection: potential role in protection against lung epithelial damages. J. Biol. Chem. 287: 8816-8829.
17. Witte, E., K. Witte, K. Warszawska, R. Sabat, and K. Wolk. 2010. Interleukin-22: a cytokine produced by T, NK and NKT cell subsets, with importance in the innate immune defense and tissue protection. Cytokine Growth Factor Rev. 21: 365-379.
18. Cella, M., A. Fuchs, W. Vermi, F. Facchetti, K. Otero, J. K. Lennerz, J. M. Doherty, J. C. Mills, and M. Colonna. 2009. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 457: 722-725.
19. H2 cells. Nat. Immunol. 10: 864-871.
20. Ferwerda, B., G. Ferwerda, T. S. Plantinga, J. A. Willment, A. B. van Spriel, H. Venselaar, C. C. Elbers, M. D. Johnson, A. Cambi, C. Huysamen, et al. 2009. Human dectin-1 deficiency and mucocutaneous fungal infections. N. Engl. J. Med. 361: 1760-1767.
21. Netea, M. G., A. Warris, J. W. Van der Meer, M. J. Fenton, T. J. Verver-Janssen, L. E. Jacobs, T. Andresen, P. E. Verweij, and B. J. Kullberg. 2003. Aspergillus fumigatus evades immune recognition during germination through loss of Toll-like receptor-4-mediated signal transduction. J. Infect. Dis. 188: 320-326. (Pubitemid 36898166)
22. Chai, L. Y., B. J. Kullberg, A. G. Vonk, A. Warris, A. Cambi, J. P. Latgé, L. A. Joosten, J. W. van der Meer, and M. G. Netea. 2009. Modulation of Toll-like receptor 2 (TLR2) and TLR4 responses by Aspergillus fumigatus. Infect. Immun. 77: 2184-2192.
23. Abdollahi-Roodsaz, S., L. A. Joosten, M. F. Roelofs, T. R. Radstake, G. Matera, C. Popa, J. W. van der Meer, M. G. Netea, and W. B. van den Berg. 2007. Inhibition of Toll-like receptor 4 breaks the inflammatory loop in autoimmune destructive arthritis. Arthritis Rheum. 56: 2957-2967. (Pubitemid 47502742)
24. Hirschfeld, M., C. J. Kirschning, R. Schwandner, H. Wesche, J. H. Weis, R. M. Wooten, and J. J. Weis. 1999. Cutting edge: inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by Toll-like receptor 2. J. Immunol. 163: 2382-2386. (Pubitemid 29399155)
25. Micallef, L., and P. Rodgers. School of Computing, University of Kent, Canterbury, U.K. Application for Drawing 3 Set Area-Proportional Venn Diagrams. Available at: http://www.eulerdiagrams.org/eulerAPE/. Accessed: September 10, 2012.
26. Rodgers, P., J. Flower, G. Stapleton, and J. Howse. 2010. Drawing Area-Proportional Venn-3 Diagrams with Convex Polygons. Lecture Notes in Computer Science 6170: 54-68.
27. Eyerich, S., J. Wagener, V. Wenzel, C. Scarponi, D. Pennino, C. Albanesi, M. Schaller, H. Behrendt, J. Ring, C. B. Schmidt-Weber, et al. 2011. IL-22 and TNF-α represent a key cytokine combination for epidermal integrity during infection with Candida albicans. Eur. J. Immunol. 41: 1894-1901.
28. Bellocchio, S., C. Montagnoli, S. Bozza, R. Gaziano, G. Rossi, S. S. Mambula, A. Vecchi, A. Mantovani, S. M. Levitz, and L. Romani. 2004. The contribution of the Toll-like/IL-1 receptor superfamily to innate and adaptive immunity to fungal pathogens in vivo. J. Immunol. 172: 3059-3069. (Pubitemid 38263695)
29. Bellocchio, S., S. Moretti, K. Perruccio, F. Fallarino, S. Bozza, C. Montagnoli, P. Mosci, G. B. Lipford, L. Pitzurra, and L. Romani. 2004. TLRs govern neutrophil activity in aspergillosis. J. Immunol. 173: 7406-7415. (Pubitemid 39628180)
30. Bochud, P. Y., J. W. Chien, K. A. Marr, W. M. Leisenring, A. Upton, M. Janer, S. D. Rodrigues, S. Li, J. A. Hansen, L. P. Zhao, et al. 2008. Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation. N. Engl. J. Med. 359: 1766-1777.
31. Mambula, S. S., K. Sau, P. Henneke, D. T. Golenbock, and S. M. Levitz. 2002. Toll-like receptor (TLR) signaling in response to Aspergillus fumigatus. J. Biol. Chem. 277: 39320-39326. (Pubitemid 35190904)
32. Meier, A., C. J. Kirschning, T. Nikolaus, H. Wagner, J. Heesemann, and F. Ebel. 2003. Toll-like receptor (TLR) 2 and TLR4 are essential for Aspergillus-induced activation of murine macrophages. Cell. Microbiol. 5: 561-570. (Pubitemid 36939595)
33. Hohl, T. M., H. L. Van Epps, A. Rivera, L. A. Morgan, P. L. Chen, M. Feldmesser, and E. G. Pamer. 2005. Aspergillus fumigatus triggers inflammatory responses by stage-specific β-glucan display. PLoS Pathog. 1: e30.
34. Steele, C., R. R. Rapaka, A. Metz, S. M. Pop, D. L. Williams, S. Gordon, J. K. Kolls, and G. D. Brown. 2005. The β-glucan receptor dectin-1 recognizes specific morphologies of Aspergillus fumigatus. PLoS Pathog. 1: e42.
35. Cunha, C., M. Di Ianni, S. Bozza, G. Giovannini, S. Zagarella, T. Zelante, C. D'Angelo, A. Pierini, L. Pitzurra, F. Falzetti, et al. 2010. Dectin-1 Y238X polymorphism associates with susceptibility to invasive aspergillosis in hematopoietic transplantation through impairment of both recipient- and donor-dependent mechanisms of antifungal immunity. Blood 116: 5394-5402.
36. Mezger, M., S. Kneitz, I. Wozniok, O. Kurzai, H. Einsele, and J. Loeffler. 2008. Proinflammatory response of immature human dendritic cells is mediated by dectin-1 after exposure to Aspergillus fumigatus germ tubes. J. Infect. Dis. 197: 924-931. (Pubitemid 351417017)
37. H-17 responses. PLoS ONE 5: e12955.
38. Gessner, M. A., J. L. Werner, L. M. Lilly, M. P. Nelson, A. E. Metz, C. W. Dunaway, Y. R. Chan, W. Ouyang, G. D. Brown, C. T. Weaver, and C. Steele. 2012. Dectin-1-dependent interleukin-22 contributes to early innate lung defense against Aspergillus fumigatus. Infect. Immun. 80: 410-417.
39. O'Brien, X. M., K. E. Heflin, L. M. Lavigne, K. Yu, M. Kim, A. R. Salomon, and J. S. Reichner. 2012. Lectin site ligation of CR3 induces conformational changes and signaling. J. Biol. Chem. 287: 3337-3348.
40. Moalli, F., A. Doni, L. Deban, T. Zelante, S. Zagarella, B. Bottazzi, L. Romani, A. Mantovani, and C. Garlanda. 2010. Role of complement and Fcγ receptors in the protective activity of the long pentraxin PTX3 against Aspergillus fumigatus. Blood 116: 5170-5180.
41. Chen, Z., and J. J. O'Shea. 2008. Regulation of IL-17 production in human lymphocytes. Cytokine 41: 71-78.
42. Aravena, O., B. Pesce, L. Soto, N. Orrego, F. Sabugo, P. Wurmann, M. C. Molina, J. Alfaro, M. Cuchacovich, J. C. Aguillón, and D. Catalán. 2011. Anti-TNF therapy in patients with rheumatoid arthritis decreases Th1 and Th17 cell populations and expands IFN-γ-producing NK cell and regulatory T cell subsets. Immunobiology 216: 1256-1263.
43. Bouzani, M., M. Ok, A. McCormick, F. Ebel, O. Kurzai, C. O. Morton, H. Einsele, and J. Loeffler. 2011. Human NK cells display important antifungal activity against Aspergillus fumigatus, which is directly mediated by IFN-γ release. J. Immunol. 187: 1369-1376.
44. H17 cells produce IFN-γ or IL-10 and are regulated by IL-1β. Nature 484: 514-518.
45. Ye, Z. J., Q. Zhou, M. L. Yuan, R. H. Du, W. B. Yang, X. Z. Xiong, B. Huang, and H. Z. Shi. 2012. Differentiation and recruitment of IL-22-producing helper T cells stimulated by pleural mesothelial cells in tuberculous pleurisy. Am. J. Respir. Crit. Care Med. 185: 660-669.
46. Matthews, K., K. A. Wilkinson, B. Kalsdorf, T. Roberts, A. Diacon, G. Walzl, J. Wolske, M. Ntsekhe, F. Syed, J. Russell, et al. 2011. Predominance of interleukin-22 over interleukin-17 at the site of disease in human tuberculosis. Tuberculosis (Edinb.) 91: 587-593.
47. Zhang, G., X. Chen, L. Chan, M. Zhang, B. Zhu, L. Wang, X. Zhu, J. Zhang, B. Zhou, and J. Wang. 2011. An SNP selection strategy identified IL-22 associating with susceptibility to tuberculosis in Chinese. Sci. Rep. 1: 20.
48. Aujla, S. J., Y. R. Chan, M. Zheng, M. Fei, D. J. Askew, D. A. Pociask, T. A. Reinhart, F. McAllister, J. Edeal, K. Gaus, et al. 2008. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat. Med. 14: 275-281. (Pubitemid 351347908)
49. Re, F., and J. L. Strominger. 2001. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells. J. Biol. Chem. 276: 37692-37699.
50. Redecke, V., H. Häcker, S. K. Datta, A. Fermin, P. M. Pitha, D. H. Broide, and E. Raz. 2004. Cutting edge: activation of Toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma. J. Immunol. 172: 2739-2743. (Pubitemid 38263655)
51. Netea, M. G., R. Sutmuller, C. Hermann, C. A. Van der Graaf, J. W. Van der Meer, J. H. van Krieken, T. Hartung, G. Adema, and B. J. Kullberg. 2004. Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells. J. Immunol. 172: 3712-3718. (Pubitemid 38337955)
52. Loures, F. V., A. Pina, M. Felonato, and V. L. Calich. 2009. TLR2 is a negative regulator of Th17 cells and tissue pathology in a pulmonary model of fungal infection. J. Immunol. 183: 1279-1290.
53. Chai, L. Y., M. G. de Boer, W. J. van der Velden, T. S. Plantinga, A. B. van Spriel, C. Jacobs, C. J. Halkes, A. G. Vonk, N. M. Blijlevens, J. T. van Dissel, et al. 2011. The Y238X stop codon polymorphism in the human β-glucan receptor dectin-1 and susceptibility to invasive aspergillosis. J. Infect. Dis. 203: 736-743.
54. Bhat, N., P. Y. Perera, J. M. Carboni, J. Blanco, D. T. Golenbock, T. N. Mayadas, and S. N. Vogel. 1999. Use of a photoactivatable taxol analogue to identify unique cellular targets in murine macrophages: identification of murine CD18 as a major taxol-binding protein and a role for Mac-1 in taxol-induced gene expression. J. Immunol. 162: 7335-7342. (Pubitemid 29277709)
55. 2 ligand binding promiscuity. J. Biol. Chem. 277: 48635-48642.
56. Wright, S. D., and M. T. Jong. 1986. Adhesion-promoting receptors on human macrophages recognize Escherichia coli by binding to lipopolysaccharide. J. Exp. Med. 164: 1876-1888. (Pubitemid 17217970)
57. Ehlers, M. R. 2000. CR3: a general purpose adhesion-recognition receptor essential for innate immunity. Microbes Infect. 2: 289-294. (Pubitemid 30167662)
58. Murphy, E. A., J. M. Davis, and M. D. Carmichael. 2010. Immune modulating effects of β-glucan. Curr. Opin. Clin. Nutr. Metab. Care 13: 656-661.
59. Gafa, V., R. Lande, M. C. Gagliardi, M. Severa, E. Giacomini, M. E. Remoli, R. Nisini, C. Ramoni, P. Di Francesco, D. Aldebert, et al. 2006. Human dendritic cells following Aspergillus fumigatus infection express the CCR7 receptor and a differential pattern of interleukin-12 (IL-12), IL-23, and IL-27 cytokines, which lead to a Th1 response. Infect. Immun. 74: 1480-1489. (Pubitemid 43346780)
60. + T cells lacking IL-17 production. Proc. Natl. Acad. Sci. USA 106: 21795-21800.
61. Duhen, T., R. Geiger, D. Jarrossay, A. Lanzavecchia, and F. Sallusto. 2009. Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat. Immunol. 10: 857-863.
62. Alderson, J. W., T. G. Van Dinter, Jr., M. J. Opatowsky, and E. C. Burton. 2005. Disseminated aspergillosis following infliximab therapy in an immunosuppressed patient with Crohn's disease and chronic hepatitis C: a case study and review of the literature. MedGenMed 7: 7.
63. De Rosa, F. G., D. Shaz, A. C. Campagna, P. E. Dellaripa, U. Khettry, and D. E. Craven. 2003. Invasive pulmonary aspergillosis soon after therapy with infliximab, a tumor necrosis factor-α-neutralizing antibody: a possible healthcare-associated case? Infect. Control Hosp. Epidemiol. 24: 477-482. (Pubitemid 36919265)
64. Warris, A., A. Bjørneklett, and P. Gaustad. 2001. Invasive pulmonary aspergillosis associated with infliximab therapy. N. Engl. J. Med. 344: 1099-1100. (Pubitemid 32267986)
65. Sainz, J., I. Salas-Alvarado, E. López-Fernández, C. Olmedo, A. Comino, F. García, A. Blanco, S. Gómez-Lopera, S. Oyonarte, P. Bueno, and M. Jurado. 2010. TNFR1 mRNA expression level and TNFR1 gene polymorphisms are predictive markers for susceptibility to develop invasive pulmonary aspergillosis. Int. J. Immunopathol. Pharmacol. 23: 423-436.